Compare · 3 funds side by side · dividends reinvested

MDEV, IXJ and XLV

Story of the three · Growth5Y$10,000 five years agoDividends reinvested · all three on one scale$14,979XLV · best of the three

02 / 04

MDEV, IXJ and XLV, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

State Street Health Care Select Sector SPDR ETFSectors · Health care0.08%1.38%+20.9%+29.0%+15.9%+8.4%−10.5%16.8%$49.9B1.1

iShares Global Healthcare ETFSectors · Health care0.38%1.28%+17.0%+25.1%+14.0%+6.7%−10.8%16.3%$4.6B1.9

First Trust Indxx Medical Devices ETFSectors · Health care0.70%0.10%+7.9%+11.0%+9.0%−2.4%−18.2%17.4%$3M3.0

Rank among the three1st → 3rdFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 6, 2026 · returns include dividends · since: MDEV 2021 · IXJ 2001 · XLV 1998

Head to Head

Swap sides Versus in desk

Head to Head

First Trust Indxx Medical Devices ETF · $3M$8,839

MDEV

IXJ

iShares Global Healthcare ETF · $4.6B$13,862

$10,000 five years ago, dividends reinvested · they hold 18.8% in common

MDEVMeasureIXJ

+7.9%Year to dateJan 1 → Nov 6+17.0%

+11.0%1 yearTotal return+25.1%

+9.0%3 years · per year$10,000 became $12,957 · $14,818+14.0%

−2.4%5 years · per year$10,000 became $8,839 · $13,862+6.7%

0.70%Expense ratio$70 · $38 a year on $10k · lower is better0.38%

0.10%Trailing 12-mo yield$10 · $128 a year on $10k1.28%

−18.2%Worst dropSmaller is better−10.8%

17.4%VolatilityLower is calmer16.3%

MDEVIXJ Winner of the row, in its colourEach row: the bigger of the two fills its side

0–8IXJ wins

End-of-day Nov 6, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

MDEV vs IXJ: Top 5 Holdings

Today

MDEV

11.4%in top 5

IXJ

in top 531.0%

MDEVStockIXJ

not top 5LLY11.1%

not top 5JNJ6.7%

not top 5ABBV5.2%

not top 5MRK4.1%

not top 5UNH4.0%

2.4%GEHCnot top 5

2.3%PHIA.ASnot top 5

2.3%TFXnot top 5

2.2%SYKnot top 5

2.2%ZBHnot top 5

Held in common18.8%

End-of-day Nov 6, 2026 · share of each fund

MDEV vs IXJ Returns, Every Period

First TrustMDEV

−2.4%

5 years, per year

IXJiShares

+6.7%

5 years, per year

MDEVIXJFaded: behind in that period

0–4IXJ wins

End-of-day Nov 6, 2026 · dividends in · faded = behind in that period

MDEV vs XLV

YTD

First TrustMDEV

+7.9%

XLVSPDR

+20.9%

+7.9%Year to date+20.9%

−18.2%Worst drop · 1Y−10.5%

17.4%Volatility · 1Y16.8%

0.1%Yield1.4%

$3.4MAssets$49.9B

4–0XLV wins

End-of-day Nov 6, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: MDEV, IXJ, XLV

Today

0.08%lowest, XLV

FundExpense ratioFee$10k

XLV0.08%$8

IXJ0.38%$38

MDEV0.70%$70

End-of-day Nov 6, 2026 · fee on $10,000 a year

Yields: MDEV, IXJ, XLV

1.38%highest, XLV

FundTrailing yieldYield$10k

XLV1.38%$138

IXJ1.28%$128

MDEV0.10%$10

End-of-day Nov 6, 2026 · trailing 12-month yield

Income After Fees on $10,000

$130most kept, XLV

XLV$138 − $8 = $130

IXJ$128 − $38 = $90

MDEV$10 − $70 = −$60

KeptFee

End-of-day Nov 6, 2026 · yield in dollars minus the fee

Overlap: MDEV, IXJ, XLV

Today

72.6%most shared, IXJ and XLV

MDEVIXJXLV

MDEV—18.8%19.8%

IXJ18.8%—72.6%

XLV19.8%72.6%—

End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 3 ETFs

+29.0%XLV, at 16.8% volatility

IXJWorst drop−10.8%16.3% vol

XLVWorst drop−10.5%16.8% vol

MDEVWorst drop−18.2%17.4% vol

End-of-day Nov 6, 2026 · up and left is better

Paid More vs Made More

YTD

XLVIXJ

+20.9%Year to date+17.0%

1.4%Yield1.3%

+29.0%Past year+25.1%

0.08%Fee0.38%

4–0XLV wins

End-of-day Nov 6, 2026

Popular Pairs Near These Three

SCHD vs VIG

YTD

SchwabSCHD

+31.4%

VIGVanguard

+12.1%

+31.4%Year to date+12.1%

3.0%Yield1.5%

$120BAssets$109B

2–0SCHD wins

End-of-day Nov 6, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+3.2%

JEPIJ.P. Morgan

+5.3%

+3.2%Year to date+5.3%

12.8%Yield8.1%

$40.7BAssets$45.2B

1–1level

End-of-day Nov 6, 2026

SPYM vs SPY

YTD

SPDRSPYM

+8.8%

SPYSPDR

+8.7%

+8.8%Year to date+8.7%

1.1%Yield1.0%

$178BAssets$778B

2–0SPYM wins

End-of-day Nov 6, 2026